Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median survival of ~3 years. Nintedanib (NTD) has been shown to be useful in controlling interstitial lung disease (ILD) in IPF. Here we describe the experience of NTD use in IPF in a real-life setting. Objective. Our objective...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Barbara Ruaro (Yazar), Ilaria Gandin (Yazar), Riccardo Pozzan (Yazar), Stefano Tavano (Yazar), Chiara Bozzi (Yazar), Michael Hughes (Yazar), Metka Kodric (Yazar), Rossella Cifaldi (Yazar), Selene Lerda (Yazar), Marco Confalonieri (Yazar), Elisa Baratella (Yazar), Paola Confalonieri (Yazar), Francesco Salton (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: MDPI AG, 2023-02-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede